Searched for
HASIT JOSHIPURA
Larsen & Toubro Engineers Rs 1,300 crore ladder to the cloudE2E specialises in providing CPU- and GPU-based cloud computing platforms, enabling customers to conduct large-scale general and AI workloa...- For India Inc, hunt for talent goes beyond cos’ core bizThis is an emerging trend now that for many Indian companies, candidate’s competencies are more vital than industry experience.
- Larsen & Toubro ropes in GSK India's Hasit Joshipura to head corporate initiativesHasit Joshipura's appointment surprised many at L&T and even outside, given that most of his 33 years of work experience were in consumer r...
- L&T appoints former GlaxoSmithKline Pharma India MD Joshipura as head of Corporate CentreEngineering major Larsen & Toubro has appointed Hasit Joshipura as the head of its Corporate Centre, the company said Wednesday.
- GSK halves seretide price to take on CiplaAsthma patients may breathe easier as GSK has halved the prices of its Seretide inhaler in India to match that of Cipla’s competing brand S...
- Pfizer and GlaxoSmithKline initiate leadership reshuffle in face of competition from domestic playersTop multinational drug makers Pfizer and GlaxoSmithKline have initiated major reshuffle of senior leadership teams in India in face of comp...
- GlaxoSmithKline appoints Annaswamy Vaidheesh as VP South AsiaVaidheesh’s last assignment was as Vice President, Corporate Government Affairs, Asia-Pacific with Johnson & Johnson based in Singapore.
- GSK appoints Annaswamy Vaidheesh as Vice President for South AsiaVaidheesh’s last assignment was as Vice President, Corporate Government Affairs, Asia-Pacific with Johnson & Johnson based in Singapore.
- GSK India to benefit from global business swap deal with NovartisGlaxo will get Novartis’ vaccine portfolio, including anti-rabies products such as Rabipur, while transferring its smaller oncology busines...
- GlaxoSmithKline Pharma Q1 net up 37.52 per cent at Rs 169 croreGlaxoSmithKline Pharmaceuticals today reported a 37.52 per cent rise in its net profit to Rs 169.01 crore for the first quarter ended March...
- Raghuram, Nanda and Basant in race for IIM-A director's post"The committee presented three names which will be sent to the MHRD. The ministry will select one of them as the director of the institute,"
- IIM-A director may get 1 crore pay packageIIM-A is hunting for a successor to Samir Barua, now on an extension after his term ended on November 7, 2012.
- GSK not under compulsion to buy Indian companies: Hasit JoshipuraGSK will not pay exorbitant price to buy Indian companies as it is under no such compulsions, a top company executive said.
- No word from centre on IIM-A autonomyIIM-A was the first among four IIMs, Bangalore, Indore and Kozhikode, to prepare a revised MoA and submit it to the human resource developm...
- GlaxoSmithKline Pharma Q3 net dips 7.57% to Rs 145.86 crGSK Pharmaceuticals today reported 7.57 per cent decline in net profit for the third quarter ended September 30, 2011 to Rs 145.86 crore.
- GSK plans to introduce Relenza in the Indian marketUK-based drug maker GlaxoSmithKline (GSK) is in talks with the Indian government for introducing its patented drug Relenza, which is used f...
- GSK to launch 'promecta' in India by 2009-endGlaxo SmithKline Pharmaceutical on Thursday said it is looking at launching its patented medicine promecta, used in treatment of depleted p...
- Sale of fine chemicals unit props Glaxo Pharma profitBuoyed by income from ‘exceptional items’ including treasury earnings, net profit of GlaxoSmithKline Pharmaceuticals rose 9% to Rs 121.27 c...
- GlaxoSmithKline Pharma to launch more vaccines in IndiaDrug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
- Glaxosmithkline Pharmaceuticals seeks marketing partnerThe company is exploring brand in-licensing opportunities to improve its therapeutic coverage in high-growth segments such as cardiovascula...
Load More
